Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
David Nierenberg currently holds 765,150 shares of MEDCATH CORP (MDTH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David Nierenberg has been a net seller of MDTH stock. They have purchased $8.4M and sold $16.5M worth of shares.
David Nierenberg's most recent insider trade was on Dec 14, 2023, when they purchased 11,948 shares at $3.72 per share.
David Nierenberg serves as Executive at MEDCATH CORP (MDTH). They have executed 212 insider transactions totaling $24.9M over their tenure at the company.
David Nierenberg holds the position of Executive at MEDCATH CORP, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 17 years and currently hold a stake valued at $0.
David Nierenberg has shown a selling trading pattern, with $8.4M in total purchases and $16.5M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by David Nierenberg was on Oct 15, 2020, when they sold $10.0M worth of RST shares. This transaction involved 334,692 shares at $30.00 per share.
David Nierenberg currently owns 765,150 shares of MEDCATH CORP (MDTH), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of David Nierenberg's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. David Nierenberg has 212 Form 4 filings on record as an insider at MEDCATH CORP.
Set alerts for David Nierenberg and 40,000+ other insiders.